|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.75 INR | +1.80% |
|
-1.21% | +0.87% |
| Market Cap | 439M 4.6M 4.03M 3.71M 3.43M 6.51M 6.62M 44.38M 17.43M 216M 17.29M 16.91M 744M | P/E 2024 |
-16.2x | P/E 2025 | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.38B 14.42M 12.61M 11.64M 10.75M 20.39M 20.73M 139M 54.6M 678M 54.15M 52.97M 2.33B | EV / Sales 2024 |
0.69x | EV / Sales 2025 | 0.66x |
| Free-Float |
63.32% | Yield 2024 * |
-
| Yield 2025 | - |
| 04/02/22 | Mangalam Drugs & Organics : Resignation | PU |
| 1 day | +1.80% | ||
| 1 week | -1.21% | ||
| Current month | -1.39% | ||
| 1 month | -1.94% | ||
| 3 months | -11.46% | ||
| 6 months | -28.26% | ||
| Current year | +0.87% |
| 1 week | 26.63 |  | 28.75 |
| 1 month | 26.63 | | 31.05 |
| Current year | 26.51 | | 54.4 |
| 1 year | 22.8 | | 95 |
| 3 years | 22.8 | | 144.99 |
| 5 years | 22.8 | | 196.95 |
| 10 years | 20.65 | | 225.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 72 | 30/09/2011 | |
| Director of Finance/CFO | - | 06/02/2026 | |
Shweta Patel
CMP | Compliance Officer | 27 | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 02/02/2010 | |
| Director/Board Member | 75 | 05/02/2015 | |
Nidhi S. Mundada
BRD | Director/Board Member | 37 | 28/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | -1.21% | - | - | 4.5M | |
| -0.17% | +1.61% | +16.42% | +85.22% | 48.73B | |
| +1.04% | -1.02% | +69.47% | +115.88% | 35.82B | |
| -0.13% | -1.29% | -2.60% | +41.58% | 12.2B | |
| -0.71% | +0.89% | +18.28% | +97.87% | 12.11B | |
| -0.76% | +0.38% | +33.16% | +123.08% | 9.11B | |
| -0.86% | +0.37% | +52.61% | -3.54% | 7.09B | |
| +0.75% | -0.82% | +17.49% | +44.79% | 7B | |
| +0.69% | +3.25% | +19.90% | +243.91% | 6.7B | |
| +5.45% | -7.36% | -17.93% | +13.17% | 5.78B | |
| Average | +0.71% | +0.11% | +22.98% | +84.66% | 16.06B | |
| Weighted average by Cap. | +0.33% | +0.39% | +29.79% | +90.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.67B 38.52M 33.69M 31.08M 28.7M 54.46M 55.38M 371M 146M 1.81B 145M 141M 6.22B | 3.18B 33.3M 29.13M 26.86M 24.81M 47.08M 47.87M 321M 126M 1.56B 125M 122M 5.38B |
| Net income | -90.72M -951K -832K -767K -709K -1.34M -1.37M -9.17M -3.6M -44.69M -3.57M -3.49M -154M | 67.21M 705K 616K 569K 525K 996K 1.01M 6.79M 2.67M 33.11M 2.65M 2.59M 114M |
| Net Debt | 1.06B 11.09M 9.7M 8.95M 8.27M 15.69M 15.95M 107M 42M 521M 41.65M 40.75M 1.79B | 936M 9.82M 8.59M 7.92M 7.32M 13.88M 14.12M 94.65M 37.17M 461M 36.86M 36.06M 1.59B |
Employees
480
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | ₹27.75 | +1.80% | 39,870 |
| 09/07/26 | ₹27.26 | +1.23% | 36,542 |
| 08/07/26 | ₹26.93 | -3.51% | 49,779 |
| 07/07/26 | ₹27.91 | -0.78% | 22,088 |
| 06/07/26 | ₹28.13 | +0.14% | 16,660 |
- Stock Market
- Stocks
- 532637 Stock
- MANGALAM Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
